Search references

• 30 May 2017 - Drug Updates

Finasteride 1 mg (Propecia): Reports of depression and suicidal thoughts in men

Advise patients to discontinue treatment immediately if episodes of depressive illness and suicidal thoughts are reported.

• 23 Mar 2017 - Drug Updates

Pilot website to report adverse reactions of psychoactive substances

Illicit drug reaction reporting form made available for healthcare professionals,

• 8 Mar 2017 - Drug Updates

Hyoscine butylbromide: serious adverse effects in cardiac patients

9 fatalities have been reported so far.

• 24 Jan 2017 - Drug Updates

Apremilast (Otezla▼): risk of psychiatric symptoms

Increased risk for depression and suicidality in apremilast users.

• 23 Jan 2017 - Drug Updates

Direct-acting antivirals for chronic HCV (interferon-free): risk of hepatitis B reactivation

Co-infected patients require close monitoring.

• 9 Nov 2016 - Drug Updates

Brimonidine gel (Mirvaso▼): reports of symptom exacerbation

New prescribing advice released for brimonidine topical gel

• 16 Sep 2016 - Drug Updates

Idelalisib (Zydelig▼): updated safety information on risk of infection

Treatment recommendations for idelalisib have been updated following conclusion of safety review

• 16 Sep 2016 - Drug Updates

Posaconazole (Noxafil): tablets and oral suspension not interchangable

Different dosage forms of posaconazole should not be substituted for each other

• 16 Sep 2016 - Drug Updates

Levonorgestrel-containing emergency contraceptives: interaction with hepatic enzyme inducers

Concomitant CYP3A4 enzyme inducers reduce the efficacy of levonorgestrel

• 31 May 2016 - Drug Updates

Interim measures following signal of serious infection and mortality associated with idelalisib (Zydelig▼)

New interim treatment recommendations for idelalisib for chronic lymphocytic leukaemia and follicular lymphoma